A previous study (46) reported that tumor-infiltrating CD4+ T cells can upregulate some immune checkpoint genes, including PD-1, T-cell immunoglobulin, mucin domain-3, cytotoxic T lymphocyte associated protein-4, and lymphocyte-activation-gene-3. The gene discussed is CTLA4; the disease is neoplasm.